Prescriber's Corner
Ipilimumab
Sarah Bertone, PharmD, and Kathy Diener Dasse, PharmD, BCOP
From The University of Michigan Health System and College of Pharmacy, Ann Arbor, Michigan
The authors have no conflicts of interest to disclose.
Correspondence to: Kathy Diener Dasse, PharmD, BCOP, The University of Michigan Health System and College of Pharmacy, Michigan House, Drug Information Services, Room 2202, 2301 Commonwealth Boulevard, Ann Arbor, MI 48105-2967. E-mail: kdasse@med.umich.edu
J Adv Pract Oncol 2011;2:323–332 |
DOI:10.1000/182 |
© 2011 Harborside Press®
For access to the full length article, please
sign in.
